Skip to Main Content

Paper Details

Lymphocyte activation gene-3-associated protein networks are associated with HDL-cholesterol and mortality in the Trans-omics for Precision Medicine program.
Commun Biol
3
2022
B2M, C1S, Deficiency of the immune checkpoint lymphocyte activation gene-3 (LAG3) protein, EBV, EBV-transformed cell lines, FHS, HDL-C, HDL-cholesterol, LAG3, LAG3 rs3782735 variant, LRIG3, Lymphocyte activation gene-3-associated protein networks, TNFRSF1A, all, cholesterol, coronary heart disease, genetic variants, lymphocyte activation gene-3, myocardial, participants, plasma LAG3
Author NameAffiliation
Ani ManichaikulCenter for Public Heath Genomics, University of Virginia
Honghuang LinUniversity of Massachusetts Medical School
Stephen S RichCenter for Public Heath Genomics, University of Virginia
Kent D TaylorThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Xiuqing GuoThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Stephen S RichThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Elaine CornellUniversity of Vermont
Russell P TracyUniversity of Vermont
Yongmei LiuDuke University
Ramachandran S VasanUniversity of Massachusetts Medical School
Laura Adrienne CupplesBoston University School of Public Health
Robert E GersztenBeth Israel Deaconess Medical Center
Clary B ClishBroad Institute
Clary B ClishBroad Institute
Deepti JainUniversity of Washington
Matthew P ConomosUniversity of Washington
Thomas W BlackwellUniversity of Michigan ann arbor
George J PapanicolaouNational Institutes of Health
  • 1 - 18

Datasets

Release 1.2